San Diego – based Empirico is a drug discovery company employing customized data models and algorithms, as well as a huge dataset of health information from millions of individuals, to uncover causal connections between genes, proteins, and clinical outcomes and find new genetically validated drug targets. The Empirico Precision Insights Platform helps the company’s scientists generate, interrogate, and prioritize hypotheses about the genetic variants behind health risks and possible ways to interfere with the mechanisms of disease.
News & Insights
Explore Companies
Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Noetik
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
Solu Therapeutics
Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules